Contract Regulatory Affairs Consultant NDA oncology Not right for you? We've got others

Waltham, MA
October 15th 2020
Relocation Assistance:
Apply Now

The Regulatory Affairs Consultant will provide Regulatory leadership as well as operational oversight for Elacestrant, a novel oral selective estrogen receptor degrader being developed for hormone receptor-positive advanced breast cancer. They will be responsible for devising Regulatory strategy and implementing such strategy - along with the clinical and manufacturing teams and CRO - for completion of the ongoing global pivotal Phase 3 trial RAD1901-308, and all supportive Phase 1 and clinical pharmacology studies to support an NDA filing

Fully remote role, one year contract up for renewal

Essential Responsibilities

Experience and Qualifications:


Welcome back!

Please sign in before continuing.

Forgot your password?